[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Avidity Biosciences, Inc. Common Stock (RNA)

Novartis to acquire Avidity Biosciences for $XX billion, a move that significantly strengthens its rare disease pipeline with Avidity's RNA-based therapies.

About Avidity Biosciences, Inc. Common Stock

Avidity Biosciences, Inc. is a biopharmaceutical company focused on developing RNA-based therapeutics.
Avidity Biosciences, Inc. Common Stock uses the ticker $RNA for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Avidity Biosciences, Inc. Common Stock (RNA) trading volume is up XXXXX% from the previous week.
Avidity Biosciences, Inc. Common Stock (RNA) social dominance is up XXXXXX% from the previous week.
Avidity Biosciences, Inc. Common Stock (RNA) Galaxy Score™ is up XXXXX% from the previous week.
Avidity Biosciences, Inc. Common Stock (RNA) engagements is up XXXXX% from the previous week.

Price: $XXXXX

Price 24-Hour Time-Series Raw Data
The stock price is nearing its 52-week high, driven by the news of the Novartis acquisition which offers a significant premium, leading to increased trading volume and positive sentiment.

24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXX%

1-Year High: $XXXXX on 2025-11-28
1-Year Low: $XXXXX on 2025-04-08

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Avidity Biosciences, Inc. Common Stock (RNA) is currently AltRank #1,277 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XXX
X Month: XXX +98
X Months: XXX -XXX
X Year: XXX +383
1-Year High: XXXXX on 2025-06-28
1-Year Low: XX on 2024-12-21

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +5
X Month: XX -X
X Months: XX +9
X Year: XX -X
1-Year High: XX on 2025-08-06
1-Year Low: XX on 2025-05-11

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX +79%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +268%
X Year: XXXXXXXXX +26%
1-Year High: XXXXXXX on 2025-10-26
1-Year Low: XXX on 2025-06-15

Engagements by network (24h): Reddit: XXX X: XXXXX YouTube: XX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXX -XX%
X Months: XXXXX +142%
X Year: XXXXX +60%
1-Year High: XXXXX on 2025-10-28
1-Year Low: XX on 2025-05-03

Mentions by network (24h): Reddit: XX X: XXX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Avidity Biosciences, Inc. Common Stock (RNA) in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -XXXX%
X Month: XXX -XX%
X Months: XXXXX +266%
X Year: XXXXX +119%
1-Year High: XXX on 2025-10-28
1-Year Low: XX on 2025-05-03

The most influential creators that mention Avidity Biosciences, Inc. Common Stock in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@RNAiAnalyst	X	XXXXXX	X	XXX
@PersimmonTI	X	XXXXXX	X	XXX
@seedytx19	X	XXXXX	X	XXX
@ParadiseTraderr	X	XXX	X	XX
@JoseRestonVA	X	XXXXX	X	XX
@BiopharmIQ	X	XXXXXX	X	XX
@BuyTheUgly	X	XX	X	XX
@AnotherBio	X	XXXXX	X	XX
@Hall8Jack	X	XXXXX	X	XX
@tajSalter85175	XX	XX	X	X

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-02-21
1-Year Low: XX% on 2025-12-07

Most Supportive Themes:

Novartis Acquisition: (80%) Novartis is acquiring Avidity Biosciences for $XX billion, significantly bolstering its rare disease pipeline with Avidity's RNA-based therapies.
RNA Therapeutics Pipeline: (15%) Avidity's proprietary Antibody Oligonucleotide Conjugates (AOCs) platform and late-stage RNA therapies are key assets driving the acquisition.

Most Critical Themes:

Clinical Holds and Discontinuations: (5%) Concerns exist regarding potential clinical holds and discontinuations in related RNA therapies, which could impact future developments.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXX%
X Week: XXXXX% +0.016%
X Month: XXXXX% -XXXXXX%
X Months: XXXXX% +0.003%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-10-28
1-Year Low: XXXXXX% on 2025-05-13

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-12-02
1-Year Low: XXXXXX% on 2025-03-11

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX +$0.08%
X Month: $XXXXXXXXXXXXXX +$1.10%
X Months: $XXXXXXXXXXXXXX +$185%
X Year: $XXXXXXXXXXXXXX +$168%
1-Year High: $XXXXXXXXXXXXXX on 2025-11-28
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08

Top Avidity Biosciences, Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Long-term buying opportunities worth paying attention to: $HIMS $OSCR $BULL $PATH $SOUN $NVO $UNH $GLXY $WOLF $DFDV $NXTT $QUBT $DRUG $RGC $BTQ $SLB $HAL $OXY $COP $PXD $RIC $RDNT $GNE $AXSM $IDYA $KYMR $BRZE $SYRE $DENLI $XENE $RIOT $RNA $ACLX $GILD $BIO"
X Link @SMALLCAPSAXIS 2025-12-10T20:00Z XXX followers, 1079 engagements

"Small caps watchlist #1 $SCNX#2 $VSEE #3 $MSPR#4 $CHR#5 $FGL #6 $BULL#7 $WOK#8 $ABP#9 $ALPS #10 $YDKG $WTO #11 $ORIS #12 $HTZ $YETI $IMTE $O $AAGH $RCAT $GNE $AXSM $IDYA $KYMR $BRZE $SYRE $DENLI $XENE $RIOT $RNA $ACLX $BIO $BHVN $AXSM $BNTX $EXEL $REGN $VRTX $BBIO $DCTH"
X Link @ParadiseTraderr 2025-12-10T18:34Z XXX followers, XXX engagements

"WATCHLIST #1 $ASST#2 $SGBX #3 $OPEN#4 $BYND $X #5 $NIXX #6 $BULL #7 $MLSS #8 $PFSA XXX% #9 $RVYL#10 $RUBI #11 $BQ $IDYA $KYMR $BRZE $SYRE $DENLI $XENE $RIOT $RNA $ACLX $GILD $BIO $VRTX $AMGN $INCY $BHVN $BBIO $ECL $SHW $MOS $FMC $IP $APD $WRK $NUE $IFF $MLM $OLN $CC"
X Link @ChirpSavvy 2025-12-10T18:23Z XXX followers, XXX engagements

"$dyn DMD data and capital raise set foundation for critical talks at #JPM26. It's either pay $9B now or wait for DM1 readout and pay double*. Novartis CEO said they would have had to pay double (2*$12B) for $RNA if they had waited for DM1 results. I believe $dyn DM1 drug superior to $rna based on splicing index"
X Link @RNAiAnalyst 2025-12-10T08:41Z 20.8K followers, 3975 engagements